Thus, the present study further demonstrated that silencing of STEDB1 could dramatically downregulate the expression of PD-L1, thereby promoting T cell cytotoxicity to tumor cells via the FOSB/miR-22/BATF3 axis. Here, BATF3 is linked to neoplasm.